Avalo Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of AVTX for the last quarter is 571.00 k USD, and it's 141.95% higher compared to the previous quarter. The net income of Q4 23 is -8.17 M USD.